They are developing a prospective, randomized, comparative study to evaluate the efficacy of anticancer chemotherapy in predicting prognosis and determining chemotherapy method in early Hormone Receptor-positive breast cancer patients.
| Contact Details | 15F G-HIGHCITY, 243 Digital-ro, Guro-gu, Seoul, Korea TEL: +82-2-2621-7038 |
|---|
Find out more companies
Related products
-
DiagnosticsMedPacto
-
-
-
-
